WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
CYCN
CYCLERION THERAPEUTICS INC
$8.24MN/A0.00%N/AN/AN/AN/A
TRVI
TREVI THERAPEUTICS INC
$197.23MN/A0.00%N/AN/AN/AN/A
DTIL
PRECISION BIOSCIENCES INC
$72.48MN/A0.00%N/AN/AN/AN/A
TERN
TERNS PHARMACEUTICALS INC
$328.43MN/A0.00%N/AN/AN/AN/A
LSTA
LISATA THERAPEUTICS INC
$23.70MN/A0.00%N/AN/AN/AN/A
LFMD
LIFEMD INC
$469.86MN/A0.00%N/AN/AN/AN/A
SRTS
SENSUS HEALTHCARE INC
$59.18MN/A0.00%N/AN/AN/AN/A
LABP
LANDOS BIOPHARMA INC
$69.48MN/A0.00%N/AN/AN/AN/A
TTNP
TITAN PHARMACEUTICALS INC
$6.13MN/A0.00%N/AN/AN/AN/A
BPMC
BLUEPRINT MEDICINES CORP
$5.81BN/A0.00%N/AN/AN/AN/A
ICAD
ICAD INC
$37.95MN/A0.00%N/AN/AN/AN/A
CRDF
CARDIFF ONCOLOGY INC
$188.98MN/A0.00%N/AN/AN/AN/A
RIGL
RIGEL PHARMACEUTICALS INC
$191.16MN/A0.00%N/AN/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$661.18MN/A0.00%N/AN/AN/AN/A
TELA
TELA BIO INC
$114.13MN/A0.00%N/AN/AN/AN/A
IRTC
IRHYTHM TECHNOLOGIES INC
$3.46BN/A0.00%N/AN/AN/AN/A
DNA
GINKGO BIOWORKS HOLDINGS INC
$1.81BN/A0.00%N/AN/AN/AN/A
LRMR
LARIMAR THERAPEUTICS INC
$468.93MN/A0.00%N/AN/AN/AN/A
CLPT
CLEARPOINT NEURO INC
$146.21MN/A0.00%N/AN/AN/AN/A
PMCB
PHARMACYTE BIOTECH INC
$18.03MN/A0.00%N/AN/AN/AN/A
FDMT
4D MOLECULAR THERAPEUTICS INC
$1.26BN/A0.00%N/AN/AN/AN/A
NVNO
ENVVENO MEDICAL CORP
$68.32MN/A0.00%N/AN/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$412.74MN/A0.00%N/AN/AN/AN/A
SNSE
SENSEI BIOTHERAPEUTICS INC
$31.59MN/A0.00%N/AN/AN/AN/A
OMIC
SINGULAR GENOMICS SYSTEMS INC
$30.09MN/A0.00%N/AN/AN/AN/A
TBPH
THERAVANCE BIOPHARMA INC
$425.78MN/A0.00%N/AN/AN/AN/A
HOWL
WEREWOLF THERAPEUTICS INC
$257.28MN/A0.00%N/AN/AN/AN/A
SDGR
SCHRODINGER INC
$1.84BN/A0.00%N/AN/AN/AN/A
AUGX
AUGMEDIX INC
$123.31MN/A0.00%N/AN/AN/AN/A
NURO
NEUROMETRIX INC
$8.82MN/A0.00%N/AN/AN/AN/A
IOBT
IO BIOTECH INC
$102.12MN/A0.00%N/AN/AN/AN/A
ATOS
ATOSSA THERAPEUTICS INC
$191.72MN/A0.00%N/AN/AN/AN/A
BOLT
BOLT BIOTHERAPEUTICS INC
$42.70MN/A0.00%N/AN/AN/AN/A
RLAY
RELAY THERAPEUTICS INC
$873.65MN/A0.00%N/AN/AN/AN/A
AVXL
ANAVEX LIFE SCIENCES CORP
$303.00MN/A0.00%N/AN/AN/AN/A
CLDX
CELLDEX THERAPEUTICS INC
$2.20BN/A0.00%N/AN/AN/AN/A
ATXS
ASTRIA THERAPEUTICS INC
$521.58MN/A0.00%N/AN/AN/AN/A
PROF
PROFOUND MEDICAL CORP
$159.21MN/A0.00%N/AN/AN/AN/A
ABIO
ARCA BIOPHARMA INC
$47.15MN/A0.00%N/AN/AN/AN/A
DMTK
DERMTECH INC
$21.36MN/A0.00%N/AN/AN/AN/A
TVTX
TRAVERE THERAPEUTICS INC
$456.59MN/A0.00%N/AN/AN/AN/A
ETNB
89BIO INC
$818.14MN/A0.00%N/AN/AN/AN/A
OM
OUTSET MEDICAL INC
$143.94MN/A0.00%N/AN/AN/AN/A
EVGN
EVOGENE LTD
$36.22MN/A0.00%N/AN/AN/AN/A
NEO
NEOGENOMICS INC
$1.78BN/A0.00%N/AN/AN/AN/A
STIM
NEURONETICS INC
$105.78MN/A0.00%N/AN/AN/AN/A
ELVN
ENLIVEN THERAPEUTICS INC
$748.39MN/A0.00%N/AN/AN/AN/A
NRC
NATIONAL RESEARCH CORP
$826.32M4.27%117.50%$0.1200$1.4871%4
PULM
PULMATRIX INC
$6.90MN/A0.00%N/AN/AN/AN/A
PACS
PACS GROUP INC
N/AN/A0.00%N/AN/AN/AN/A
BYSI
BEYONDSPRING INC
$80.40MN/A0.00%N/AN/AN/AN/A
PHAR
PHARMING GROUP NV
$701.27MN/A0.00%N/AN/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.53BN/A0.00%N/AN/AN/AN/A
RXRX
RECURSION PHARMACEUTICALS INC
$1.96BN/A0.00%N/AN/AN/AN/A
CMAX
CAREMAX INC
$15.06MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$102.29MN/A0.00%N/AN/AN/AN/A
OCUL
OCULAR THERAPEUTIX INC
$746.11MN/A0.00%N/AN/AN/AN/A
NARI
INARI MEDICAL INC
$2.42BN/A0.00%N/AN/AN/AN/A
MNKD
MANNKIND CORP
$1.17BN/A0.00%N/AN/AN/AN/A
URGN
UROGEN PHARMA LTD
$491.36MN/A0.00%N/AN/AN/AN/A
ICCM
ICECURE MEDICAL LTD
$53.50MN/A0.00%N/AN/AN/AN/A
GTHX
G1 THERAPEUTICS INC
$215.92MN/A0.00%N/AN/AN/AN/A
ECOR
ELECTROCORE INC
$36.26MN/A0.00%N/AN/AN/AN/A
QIPT
QUIPT HOME MEDICAL CORP
$153.67MN/A0.00%N/AN/AN/AN/A
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$404.81MN/A0.00%N/AN/AN/AN/A
FOLD
AMICUS THERAPEUTICS INC
$3.08BN/A0.00%N/AN/AN/AN/A
OCGN
OCUGEN INC
$357.68MN/A0.00%N/AN/AN/AN/A
EXAS
EXACT SCIENCES CORP
$10.89BN/A0.00%N/AN/AN/AN/A
AKYA
AKOYA BIOSCIENCES INC
$194.60MN/A0.00%N/AN/AN/AN/A
RPTX
REPARE THERAPEUTICS INC
$139.20MN/A0.00%N/AN/AN/AN/A
CANF
CAN-FITE BIOPHARMA LTD
$8.53MN/A0.00%N/AN/AN/AN/A
MRNA
MODERNA INC
$42.59BN/A0.00%N/AN/AN/AN/A
BFLY
BUTTERFLY NETWORK INC
$165.83MN/A0.00%N/AN/AN/AN/A
AMWL
AMERICAN WELL CORP
$157.42MN/A0.00%N/AN/AN/AN/A
TCRT
ALAUNOS THERAPEUTICS INC
$20.66MN/A0.00%N/AN/AN/AN/A
BGLC
BIONEXUS GENE LAB CORP
$10.85MN/A0.00%N/AN/AN/AN/A
PNTG
PENNANT GROUP INC
$638.07MN/A0.00%N/AN/AN/AN/A
LNSR
LENSAR INC
$34.98MN/A0.00%N/AN/AN/AN/A
BLRX
BIOLINERX LTD
$48.92MN/A0.00%N/AN/AN/AN/A
TLPH
TALPHERA INC
$16.97MN/A0.00%N/AN/AN/AN/A
AADI
AADI BIOSCIENCE INC
$47.64MN/A0.00%N/AN/AN/AN/A
SILO
SILO PHARMA INC
$5.23MN/A0.00%N/AN/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$791.84MN/A0.00%N/AN/AN/AN/A
SYRA
SYRA HEALTH CORP
$14.66MN/A0.00%N/AN/AN/AN/A
INVA
INNOVIVA INC
$962.95MN/A0.00%$0.2500N/AN/A0
BRTX
BIORESTORATIVE THERAPIES INC
$9.27MN/A0.00%N/AN/AN/AN/A
STOK
STOKE THERAPEUTICS INC
$535.27MN/A0.00%N/AN/AN/AN/A
IMRN
IMMURON LTD
$14.12MN/A0.00%N/AN/AN/AN/A
HOOK
HOOKIPA PHARMA INC
$88.96MN/A0.00%N/AN/AN/AN/A
IPHA
INNATE PHARMA SA
$204.35MN/A0.00%N/AN/AN/AN/A
CLLS
CELLECTIS SA
$181.96MN/A0.00%N/AN/AN/AN/A
EVH
EVOLENT HEALTH INC
$3.15BN/A0.00%N/AN/AN/AN/A
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$580.80MN/A0.00%N/AN/AN/AN/A
PSTX
POSEIDA THERAPEUTICS INC
$267.27MN/A0.00%N/AN/AN/AN/A
BNR
BURNING ROCK BIOTECH LTD
$76.63MN/A0.00%N/AN/AN/AN/A
OCX
ONCOCYTE CORP
$21.10MN/A0.00%N/AN/AN/AN/A
CRVO
CERVOMED INC
$149.14MN/A0.00%N/AN/AN/AN/A
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$2.12BN/A0.00%N/AN/AN/AN/A
RDNT
RADNET INC
$3.45BN/A0.00%N/AN/AN/AN/A
LGND
LIGAND PHARMACEUTICALS INC
$1.26BN/AN/AN/AN/AN/AN/A
1...456...12

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
682+2.73%+3.18%-7.19%-21.03%7.71x6.02x-68.56%+3.07%+21.74%+84.82%Strong Buy
66+0.70%-0.56%-6.06%-2.35%38.50x4.18x-22.82%+6.39%+10.99%+11.35%Buy
17+0.52%+3.18%-0.94%+13.75%151.40x6.24x+34.95%+8.30%+14.47%+13.15%Buy
90+0.48%+3.46%-1.40%-6.22%32.65x2.12x+11.34%+2.71%+5.06%+33.93%Strong Buy
12-0.30%-2.39%-5.75%-2.55%18.65x2.84x+19.97%+6.14%+14.20%+17.58%Buy
61+0.90%-0.31%-7.89%-25.07%75.21x3.28x+6.22%+2.03%+5.22%+36.70%Buy
51+0.26%-1.00%-5.53%+5.10%-1.05x4.40x-80.36%+6.53%+13.61%+17.61%Buy
154+2.20%+0.21%-4.02%-15.23%30.19x3.68x+10.60%+5.30%+7.71%+21.30%Buy
9-1.68%-1.91%-3.95%+32.84%25.61x124.98x-7.98%+3.49%+19.48%+8.16%Buy
56+0.51%+0.32%-3.15%-12.42%55.14x3.53x+11.66%+7.78%+10.33%+20.96%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the top healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -5.36% over the past year, overperforming other healthcare stocks by 5 percentage points.

2. Progyny (NASDAQ:PGNY)


Progyny (NASDAQ:PGNY) is the second best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -3.87% over the past year, overperforming other healthcare stocks by 6 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 45.56% from Progyny's current stock price of $32.29.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the third best healthcare stock with a Zen Score of 65, which is 40 points higher than the healthcare sector average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Inmode has seen its stock lose -54.14% over the past year, underperforming other healthcare stocks by -44 percentage points.

Inmode has an average 1 year price target of $27.00, an upside of 56.61% from Inmode's current stock price of $17.24.

Inmode stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Inmode, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.8%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.27%, which is 8 percentage points higher than the healthcare sector average of 2.8%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.95%, which is 5 percentage points higher than the healthcare sector average of 2.8%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 158.2% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.29% in the last day, and up 0.91% over the last week. Cytomx Therapeutics was the among the top gainers in the healthcare sector, gaining 214.72% yesterday.

CytomX Therapeutics shares are trading higher after the company announced that it will report Q1 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -42.17% in the past year. It has underperformed other stocks in the healthcare sector by -32 percentage points.

2. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -54.14% in the past year. It has underperformed other stocks in the healthcare sector by -44 percentage points.

3. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -5.36% in the past year. It has overperformed other stocks in the healthcare sector by 5 percentage points.

Are healthcare stocks a good buy now?

47.87% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 37.59% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 70.86x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.